Matrix metalloproteases and their tissue inhibitor in cardiac transplantation

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 1, 2007, Pages 48-51

  Aharinejad, Seyedhossein ^a,b   Krenn, Katharina ^a,b   Zuckermann, Andreas ^a   Schäfer, Romana ^b   Paulus, Patrick ^b   Seebacher, Gernot ^a   Wolner, Ernst ^a   Grimm, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University of Vienna   (Austria)

Author keywords

Cardiac transplantation; Matrix metalloproteases

Indexed keywords

CYCLOSPORIN A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL COLLAGENASE; PREDNISOLONE; TACROLIMUS; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ALLOGRAFT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; POSTOPERATIVE PERIOD; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 34249891624     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.04.007     Document Type: Article

References (16)

1. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
2. Shapiro S.D., and Senior R.M. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20 (1999) 1100-1102
3. Goetzl E.J., Banda M.J., and Leppert D. Matrix metalloproteinases in immunity. J Immunol 156 (1996) 1-4
4. Falk V., Soccal P.M., Grunenfelder J., Hoyt G., Walther T., and Robbins R.C. Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. Eur J Cardiothorac Surg 22 (2002) 53-58
5. Campbell L.G., Ramachandran S., Liu W., Shipley J.M., Itohara S., Rogers J.G., Moazami N., Senior R.M., and Jaramillo A. Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. Am J Transplant 5 (2005) 517-528
6. Suzuki J., Isobe M., Kawauchi M., Endoh M., Amano J., and Takamoto S. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates. Transpl Int 13 (2000) 106-113
7. Rajasekhar L., Liou L.B., Chan C.Y., Tsai W.P., and Cheng C.Y. Matrix metalloproteinase-8 in sera and from polymorphonuclear leucocytes in rheumatoid arthritis: in vitro characterization and correlation with disease activity. Clin Exp Rheumatol 22 (2004) 597-602
8. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., Proost P., and Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (2001) 851-859
9. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74 (1997) 111-122
10. Schupp D.J., Huck B.P., Sykora J., Flechtenmacher C., Gorenflo M., Koch A., Sack F.U., Haass M., Katus H.A., Ulmer H.E., Hagl S., Otto H.F., and Schnabel P.A. Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation. Virchows Arch 448 (2006) 184-194
11. Dorent R., Beaudeux J.L., Tezenas S., Ghossoub J.J., Roussouliere A.L., Leger P., Vaissier E., Bonnet N., Leprince P., Regan M., Pavie A., Foglietti M.J., Cacoub P., and Gandjbakhch I. Circulating levels of matrix metalloproteinases in heart transplant recipients. Transplant Proc 32 (2000) 2750-2751
12. Costanzo M.R., Augustine S., Bourge R., Bristow M., O'Connell J.B., Driscoll D., and Rose E. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
13. Aharinejad S., Krenn K., Paulus P., Schafer R., Zuckermann A., Grimm M., and Abraham D. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant 5 (2005) 2185-2192
14. Joffs C., Gunasinghe H.R., Multani M.M., Dorman B.H., Kratz J.M., Crumbley III A.J., Crawford Jr. F.A., and Spinale F.G. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases. Ann Thorac Surg 71 (2001) 1518-1523
15. Lin T.C., Li C.Y., Tsai C.S., Ku C.H., Wu C.T., Wong C.S., and Ho S.T. Neutrophil-mediated secretion and activation of matrix metalloproteinase-9 during cardiac surgery with cardiopulmonary bypass. Anesth Analg 100 (2005) 1554-1560
16. Malik N., Greenfield B.W., Wahl A.F., and Kiener P.A. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 156 (1996) 3952-3960